image
Healthcare - Medical - Care Facilities - NYSE - US
$ 144.0
0.742 %
$ 11.1 B
Market Cap
13.29
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one DVA stock under the worst case scenario is HIDDEN Compared to the current market price of 144 USD, DaVita Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one DVA stock under the base case scenario is HIDDEN Compared to the current market price of 144 USD, DaVita Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one DVA stock under the best case scenario is HIDDEN Compared to the current market price of 144 USD, DaVita Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DVA

image
$180.0$180.0$175.0$175.0$170.0$170.0$165.0$165.0$160.0$160.0$155.0$155.0$150.0$150.0$145.0$145.0$140.0$140.0$135.0$135.0$130.0$130.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
12.8 B REVENUE
5.56%
2.09 B OPERATING INCOME
30.43%
1.25 B NET INCOME
80.86%
2.02 B OPERATING CASH FLOW
-1.80%
-771 M INVESTING CASH FLOW
0.05%
-817 M FINANCING CASH FLOW
30.21%
3.29 B REVENUE
0.95%
565 M OPERATING INCOME
5.70%
349 M NET INCOME
18.08%
548 M OPERATING CASH FLOW
-32.43%
-248 M INVESTING CASH FLOW
-72.82%
-556 M FINANCING CASH FLOW
-5017.61%
Balance Sheet DaVita Inc.
image
Current Assets 3.75 B
Cash & Short-Term Investments 846 M
Receivables 2.56 B
Other Current Assets 342 M
Non-Current Assets 13.5 B
Long-Term Investments 337 M
PP&E 5.33 B
Other Non-Current Assets 7.87 B
4.89 %14.80 %30.86 %45.52 %Total Assets$17.3b
Current Liabilities 2.97 B
Accounts Payable 547 M
Short-Term Debt 0
Other Current Liabilities 2.43 B
Non-Current Liabilities 12.2 B
Long-Term Debt 9.18 B
Other Non-Current Liabilities 3.04 B
3.60 %15.97 %60.39 %20.04 %Total Liabilities$15.2b
EFFICIENCY
Earnings Waterfall DaVita Inc.
image
Revenue 12.8 B
Cost Of Revenue 8.6 B
Gross Profit 4.22 B
Operating Expenses 2.13 B
Operating Income 2.09 B
Other Expenses 840 M
Net Income 1.25 B
14b14b12b12b10b10b8b8b6b6b4b4b2b2b0013b(9b)4b(2b)2b(840m)1bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
32.91% GROSS MARGIN
32.91%
16.31% OPERATING MARGIN
16.31%
7.31% NET MARGIN
7.31%
773.06% ROE
773.06%
5.42% ROA
5.42%
11.94% ROIC
11.94%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DaVita Inc.
image
2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 1.25 B
Depreciation & Amortization 724 M
Capital Expenditures -555 M
Stock-Based Compensation 103 M
Change in Working Capital 0
Others 2.49 M
Free Cash Flow 1.47 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DaVita Inc.
image
Wall Street analysts predict an average 1-year price target for DVA of $144 , with forecasts ranging from a low of $81 to a high of $184 .
DVA Lowest Price Target Wall Street Target
81 USD -43.75%
DVA Average Price Target Wall Street Target
144 USD -0.20%
DVA Highest Price Target Wall Street Target
184 USD 27.78%
Price
Max Price Target
Min Price Target
Average Price Target
2002001801801601601401401201201001008080Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership DaVita Inc.
image
Sold
0-3 MONTHS
38.6 M USD 1
3-6 MONTHS
109 M USD 1
6-9 MONTHS
33.1 M USD 3
9-12 MONTHS
1.15 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day. zacks.com - 2 weeks ago
DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call DENVER , April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. prnewswire.com - 2 weeks ago
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day. zacks.com - 3 weeks ago
3 No-Brainer Warren Buffett Stocks to Buy Right Now In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has weathered every market storm and consistently outperformed market benchmarks. fool.com - 1 month ago
Why DaVita Stock Got Rocked This Week We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors. fool.com - 1 month ago
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close. zacks.com - 1 month ago
DaVita Says Ransomware Attack Affecting Some Operations DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations. wsj.com - 1 month ago
Dialysis firm DaVita hit by ransomware attack DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach. reuters.com - 1 month ago
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain. zacks.com - 1 month ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close. zacks.com - 1 month ago
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day. zacks.com - 1 month ago
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors. zacks.com - 1 month ago
8. Profile Summary

DaVita Inc. DVA

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 11.1 B
Dividend Yield 0.00%
Description DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Contact 2000 16th Street, Denver, CO, 80202 https://www.davita.com
IPO Date Oct. 31, 1995
Employees 76000
Officers Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer Mr. James O. Hearty Chief Compliance Officer Ms. Madhu Narasimhan Chief Information Officer Mr. David P. Maughan Chief Operating Officer of Kidney Care Nic Eliason Group Vice President of Investor Relations Mr. Javier J. Rodriguez Chief Executive Officer & Executive Director Mr. Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business Dr. Jeffrey Allen Giullian Chief Medical Officer of Kidney Care Ms. Jessica Hergenreter Chief People Officer Mr. Joel Ackerman Chief Financial Officer & Treasurer